Welcome to our dedicated page for Travelers Compan SEC filings (Ticker: TRV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Travelers Companies, Inc. filings document the disclosure record of a NYSE-listed property casualty insurer with common stock trading under TRV. Recent Form 8-K reports furnish quarterly results of operations, financial-condition updates, financial supplements and other material events tied to the company’s insurance operations and investment portfolio.
Travelers’ proxy materials cover board elections, executive compensation, pay-versus-performance disclosures and shareholder governance matters. Other filings record board composition changes, registered securities information and capital-structure activity, including senior note issuance and underwriting agreement disclosures.
The Travelers Companies, Inc. director Thomas B. Leonardi reported an equity award linked to company common stock. On February 3, 2026, he acquired 729 deferred stock units tied to Travelers common stock at a reference price of $288.23 per share.
After this award, Leonardi beneficially owns 5,834.305 shares-equivalent on a direct basis, including 79.942 deferred stock units accumulated through dividend reinvestment since February 4, 2025. These deferred stock units convert into common shares on a one-for-one basis and are distributed in a lump sum or installments after his board service ends.
The Travelers Companies, Inc. director Rafael Santana reported receiving an award of 729 deferred stock units of common stock on February 3, 2026 at a price of $288.23 per share. After this grant, he beneficially owns 4,622.338 common shares on a direct basis.
The units were granted under Travelers' Amended and Restated 2023 Stock Incentive Plan and its Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock, with distribution in a lump sum or installments starting at least six months after board service ends. The total includes 60.964 units accumulated through dividend reinvestment since February 4, 2025.
The Travelers Companies, Inc. director Russell G. Golden reported an award of 729 shares of common stock in the form of deferred stock units on February 3, 2026 at a reference price of $288.23 per share.
After this award, he beneficially owns a total of 5,260.663 shares directly. These deferred stock units were granted under the company’s Amended and Restated 2023 Stock Incentive Plan and the Deferred Compensation Plan for Non-Employee Directors. Each unit converts into one share of common stock upon distribution, which occurs in a lump sum or annual installments beginning at least six months after the director’s service ends.
Travelers (TRV) shareholder William Heyman has filed a Form 144 indicating an intent to sell 5,000 shares of Travelers common stock. The shares are to be sold through Fidelity Brokerage Services LLC on the NYSE, with an aggregate market value of $1,510,000.00 and an approximate sale date of 02/05/2026.
The filing also lists several prior sales of Travelers common stock by William Heyman during the past three months, with multiple transactions ranging from 1,000 to 4,000 shares and disclosed gross proceeds for each trade. By signing the notice, the seller represents that he does not know of any undisclosed material adverse information about Travelers’ current or prospective operations.
The Vanguard Group has filed an amended Schedule 13G reporting beneficial ownership of 22,177,978 shares of Travelers Cos Inc/The common stock, representing 10.19% of the class as of 01/30/2026.
Vanguard reports shared voting power over 2,228,435 shares and shared dispositive power over 22,177,978 shares, with no sole voting or dispositive power. The filing notes an internal realignment on 01/12/2026 under which certain Vanguard subsidiaries are expected to report beneficial ownership separately, and confirms the holdings are in the ordinary course of business without intent to influence control.
An insider plans to sell 55,733 shares of common stock under Rule 144 through Fidelity Brokerage Services on 02/04/2026, with trading on the NYSE. The planned sale has an aggregate market value of 16,424,517.04, compared with 223,063,417 shares outstanding. These shares were acquired by exercising stock options for cash on the same date.
The Travelers Companies, Inc. executive Jeffrey P. Klenk, EVP & President of Bond & Specialty Insurance, reported option exercises and a share sale. On January 23, 2026, he exercised stock options for 4,912 shares at $140.85 and 11,800 shares at $132.58, receiving equivalent amounts of Travelers common stock.
On the same date, he sold 16,712 shares of common stock in a market transaction at a weighted average price of $279.7746, with individual trades ranging from $279.60 to $280.25. After these transactions, he directly owned 6,075.303 shares of common stock and 9,016 stock options.
A holder of common stock in TRV has filed a notice of proposed sale under Rule 144. The filing covers 16,712 common shares to be sold through Fidelity Brokerage Services LLC on the NYSE, with an indicated aggregate market value of $4,675,593.46. The filing notes that 223,063,417 shares of this class were outstanding at the time referenced.
The shares to be sold were recently acquired by exercising stock options granted on 02/06/2018 and 02/04/2020, resulting in acquisitions of 4,912 and 11,800 shares, respectively, both paid in cash on 01/23/2026. The seller represents that they are not aware of any undisclosed material adverse information about the issuer’s current or prospective operations.
The Travelers Companies, Inc. filed a Form 8-K to announce that it has released its financial results for the quarter ended December 31, 2025. On January 21, 2026, the company issued a press release describing its quarterly operating results and made a detailed fourth quarter 2025 financial supplement available on its website.
The press release is furnished as Exhibit 99.1 and the financial supplement as Exhibit 99.2. These materials are designated as furnished, not filed, meaning they are not automatically subject to certain liability and incorporation provisions under U.S. securities laws unless specifically referenced in other filings.
The Travelers Companies, Inc. director reported receiving additional deferred common stock units instead of cash fees. On 12/31/2025, the director acquired 150.83 deferred common stock units at a reference price of $290.06 per share, bringing the total directly owned deferred units to 11,457.626.
These deferred common stock units are granted under the company’s Deferred Compensation Plan for Non-Employee Directors and related director compensation plans. Each unit will convert on a one-for-one basis into a share of Travelers common stock when distributions are made. The director can elect to receive distributions in a lump sum or in annual installments, and the total includes 42.719 units added on December 31, 2025 through dividend reinvestment features.